- What we do
-
-
Routes of delivery
- Oral
- Nasal
- Nose to Brain
- Pulmonary
- Parenteral
-
Development stage
- Pre-clinical
- Phase I to Phase II
- Phase III - Commercial
Our Approach
- Selecting Your CDMO Partner
- Project Management
-
- About us
-
-
A CDMO like no other
- About Us
- Our Facilities
- Our History
- Awards and Achievements
-
Leadership Expertise
- Executive Leadership Team
- Board of Directors
- Careers
-
-
- Resources
- Events
- Contact
About DCAT Week
DCAT Week is an annual event for the global biopharmaceutical manufacturing value chain. Over four days, participants engage in pre-arranged private meetings, expert-led sessions, and networking events. With more than 10,000 professionals from 700+ companies in attendance, DCAT Week offers opportunities to strengthen partnerships, initiate new collaborations, and accelerate business growth.
DCAT Week Dates, Venue & Location
Date: 23 – 26 March 2026
Address: Meet the Upperton team at Suite 1802 at The Lexington Hotel
511 Lexington Avenue at, E 48th St, New York, NY 10017, USA
Meet with Upperton Pharma Solutions
We are experts in oral solids, nasal and pulmonary dosage forms, able to support you to Phase I quickly or help you transition into Phase II and scale up to Phase III.
From pre-clinical to market, all in one place
Our flexibility and science-led approach saves time, reduces risk and provides pathways from
early-phase clinical studies to commercialisation with confidence.
One team, from start to finish
We keep the knowledge of your molecule within the same project team, ensuring continuity and access to subject matter expertise across all layers of our business.
One site, to accelerate through phases
We accelerate your molecule through clinical phases without transfer delays, with one integrated facility across R&D, GMP and QC, located in Nottingham, UK.
One destination, with a trusted track record
Our regulatory record ensures you’re in good hands to progress your drug development pipeline with quality, speed and confidence.
Discover more about our integrated CDMO services and expertise in oral, nasal and pulmonary dosage forms.

Nikki Whitfield
Chief Executive Officer

Richard Johnson
Chief Scientific Officer & Founder

Ian Lafferty
Chief Technical Officer
Request a meeting
Connect with our experts and request a meeting to learn more about our integrated CDMO services.